Procter & Gamble has dominated the household goods market since Andrew Jackson was in the White House. But the 180-year-old conglomerate is stuck.
The maker of Tide, Bounty, Charmin, Pampers, Gillette and Crest brands reported anemic sales growth last quarter and it's losing the ability to control prices and maintain high profit margins.
"This was a challenging quarter in a very tough environment," P&G chief financial officer Jon Moeller told analysts on a conference call Thursday. Wall Street analysts weren't having it: They asked Moeller tough, pointed questions, including about how the board defines success at the company.
P&G's sales inched up 1%, while prices declined 2% and margins shrank 1%. The results sent battered P&G shares 3% lower. It's this year's second-worst stock on the Dow.
Gillette's price drop was the company's steepest last quarter. Last year, P&G took down prices on the razors after losing market share to cheaper subscription upstarts Harry's and Dollar Shave Club. P&G also lowered prices on toothpaste last quarter.
P&G's struggles aren't new. The company's performance drew the attention of activist investor Nelson Peltz last year. P&G waged an expensive proxy fight with Peltz over a seat on the board. Peltz narrowly lost the fight, but P&G gave him the seat. He took it on March 1.
It's also not the only consumer goods company mired in a slump.
"We have large businesses in several difficult markets. The ecosystems in which we operate around the world are being disrupted and transformed," CEO David Taylor said in a statement.
Rivals Clorox, Unilever, Colgate-Palmolive, Kimberly-Clark, Edgewell Personal Care and Church & Dwight are facing intense pressure. Clorox lost 6% on Thursday following a Morgan Stanley stock downgrade.
Established brands have lost key advantages in the digital era.
In the past, P&G could muscle out competitors through expensive advertising campaigns, scale and supply networks, and deep relationships with retailers to get their products on store shelves in the best spots.
Today, the shopping landscape is fragmented. Smaller companies, often born online, can sell products directly to consumers. And retailers' private labels and discount stores have chipped away at big brands' market share.
Their prices often beat P&G's higher end lines.
"Competition is offering a very compelling value proposition that makes it hard for the household good companies to justify significant price premiums," said Kevin Keller, a marketing professor at the Tuck School of Business at Dartmouth University.
In addition, online sellers like Amazon have hurt suppliers by forcing brick-and-mortar stores, which have been lowering their prices to compete, to fore P&G to sell to retailers at lower costs.
P&G is betting on its consumer health care business, which already includes Vicks cold medicine and Pepto-Bismol heartburn relief, to help jumpstart sales.
On Thursday, P&G announced a $4.2 billion deal for German pharmaceutical company Merck KGaA. It will own brands like Seven Seas vitamins and Nasivin nasal spray.
"We believe personal health care will continue to be a financially attractive," Taylor said. "It's a huge category and about $230 billion in sales and with strong profit margins."